EFFECT OF PARACETAMOL ON MELANIZATION PROCESS IN HUMAN EPIDERMAL MELANOCYTES
Paracetamol (acetaminophen) is commonly used as a drug of choice for treatment of pain and fever. Unlike non-steroidal anti-inflammatory drugs (NSAIDs) it does not cause gastrointestinal damage or untoward cardiorenal effects, however cutaneous adverse effects have been reported. It is known that paracetamol binds to melanin biopolymers, but the relation between the affinity of this drug to melanin and its toxicity is not documented. The aim of this work was to examine the impact of paracetamol on melanogenesis in cultured human normal epidermal melanocytes (HEMn-DP). The effect of paracetamol on cell viability was determined by WST-1 assay, melanin content and tyrosinase activity were measured spectrophotometrically. It has been demonstrated that paracetamol induced concentration-dependent loss in melanocytes viability. The value of EC50 was found to be - 20.0 mM. The analyzed drug inhibited melanin biosynthesis in a concentration-dependent manner by decreasing the melanin content as well as the tyrosinase activity. The demonstrated inhibitory effect of paracetamol on melanization process in normal epidermal melanocytes in vitro may explain the potential role of melanin biopolymer in the mechanisms of undesirable side effects of this drug in vivo, as a result of its accumulation in pigmented tissues.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:73 |
---|---|
Enthalten in: |
Acta poloniae pharmaceutica - 73(2016), 3 vom: 29. Mai, Seite 653-8 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wrześniok, Dorota [VerfasserIn] |
---|
Themen: |
362O9ITL9D |
---|
Anmerkungen: |
Date Completed 12.09.2016 Date Revised 02.12.2018 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM262978806 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM262978806 | ||
003 | DE-627 | ||
005 | 20231224202856.0 | ||
007 | tu | ||
008 | 231224s2016 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0876.xml |
035 | |a (DE-627)NLM262978806 | ||
035 | |a (NLM)27476283 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wrześniok, Dorota |e verfasserin |4 aut | |
245 | 1 | 0 | |a EFFECT OF PARACETAMOL ON MELANIZATION PROCESS IN HUMAN EPIDERMAL MELANOCYTES |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 12.09.2016 | ||
500 | |a Date Revised 02.12.2018 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Paracetamol (acetaminophen) is commonly used as a drug of choice for treatment of pain and fever. Unlike non-steroidal anti-inflammatory drugs (NSAIDs) it does not cause gastrointestinal damage or untoward cardiorenal effects, however cutaneous adverse effects have been reported. It is known that paracetamol binds to melanin biopolymers, but the relation between the affinity of this drug to melanin and its toxicity is not documented. The aim of this work was to examine the impact of paracetamol on melanogenesis in cultured human normal epidermal melanocytes (HEMn-DP). The effect of paracetamol on cell viability was determined by WST-1 assay, melanin content and tyrosinase activity were measured spectrophotometrically. It has been demonstrated that paracetamol induced concentration-dependent loss in melanocytes viability. The value of EC50 was found to be - 20.0 mM. The analyzed drug inhibited melanin biosynthesis in a concentration-dependent manner by decreasing the melanin content as well as the tyrosinase activity. The demonstrated inhibitory effect of paracetamol on melanization process in normal epidermal melanocytes in vitro may explain the potential role of melanin biopolymer in the mechanisms of undesirable side effects of this drug in vivo, as a result of its accumulation in pigmented tissues | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Analgesics, Non-Narcotic |2 NLM | |
650 | 7 | |a Melanins |2 NLM | |
650 | 7 | |a Acetaminophen |2 NLM | |
650 | 7 | |a 362O9ITL9D |2 NLM | |
650 | 7 | |a Monophenol Monooxygenase |2 NLM | |
650 | 7 | |a EC 1.14.18.1 |2 NLM | |
700 | 1 | |a Oprzondek, Martyna |e verfasserin |4 aut | |
700 | 1 | |a Hechmann, Anna |e verfasserin |4 aut | |
700 | 1 | |a Beberok, Artur |e verfasserin |4 aut | |
700 | 1 | |a Otreba, Michał |e verfasserin |4 aut | |
700 | 1 | |a Buszman, Ewa |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Acta poloniae pharmaceutica |d 1951 |g 73(2016), 3 vom: 29. Mai, Seite 653-8 |w (DE-627)NLM000024988 |x 0001-6837 |7 nnns |
773 | 1 | 8 | |g volume:73 |g year:2016 |g number:3 |g day:29 |g month:05 |g pages:653-8 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 73 |j 2016 |e 3 |b 29 |c 05 |h 653-8 |